You are here: Industry Insights > AstraZeneca

News List

CR UK, AZ researchers pioneer new antibody maturation technique pharmatimes
September 07, 2020
Researchers at the Cancer Research UK-AstraZeneca Antibody Alliance Laboratory in Cambridge, UK, have developed a new technique able to generate an inhibitory, high-affinity antibody against Arginase 2 (ARG2), an enzyme implicated in major human diseases.
AMRI Selected to Support AstraZeneca in Delivery of COVID-19 Vaccine americanpharmaceuticalreview
September 07, 2020
Albany Molecular Research, Inc. (AMRI) has signed a supply agreement with AstraZeneca to support the manufacture of AstraZeneca’s COVID-19 vaccine candidate AZD1222, intended to protect against the SARS-CoV-2 novel coronavirus.
Phase III trials of AstraZeneca COVID-19 vaccine candidate begins in US expresspharma
September 02, 2020
AZD1222 is already undergoing late-stage clinical trials in Britain, Brazil and South Africa, with additional trials planned in Japan and Russia.
EU approves AstraZeneca’s Imfinzi for treatment of extensive-stage small cell lung cancer expresspharma
September 02, 2020
Imfinzi, in combination with etoposide and either carboplatin or cisplatin, is also approved in the US, Japan and several other countries for the treatment of ES-SCLC.
AstraZeneca's Farxiga cuts kidney disease risks by 39% in trial that could 'rewrite' the treatment textbook fiercepharma
September 01, 2020
AstraZeneca set the tone for the future of SGLT2 diabetes medicines in May with Farxiga's heart-helping FDA approval in patients with or without diabetes.
Gilead, AstraZeneca and Pfizer may be winners in race for COVID-19 therapeutics and vaccines: GlobalData expresspharma
August 31, 2020
More than 1,200 therapeutics and vaccines have entered the research and development (R&D) pipeline since January 2020, according to GlobalData, and that number grows every week.
EC signs first Covid-19 vaccine contract with AstraZeneca pharmaceutical-technology
August 28, 2020
The European Commission (EC) has signed its first contract with AstraZeneca for the supply of a Covid-19 vaccine candidate to the European Union (EU) Member States.
AstraZeneca doses first patients in COVID-19 therapy trial europeanpharmaceuticalreview
August 27, 2020
The Phase I trial will assess the safety and pharmacokinetics of the AZD7442 monoclonal antibody combination in 48 healthy participants.
WHF partners with AZ to reduce burden of CV disease pharmatimes
August 26, 2020
AstraZeneca is partnering with the World Heart Federation (WHF) to progress global action to prevent, control and reduce the burden of cardiovascular (CV) disease and its associated risks and complications.
AZ kicks off PhI trial of potential COVID-19 therapy pharmatimes
August 26, 2020
AstraZeneca has dosed the first participants in a Phase I trial of AZD7442, a combination of two monoclonal antibodies (mAbs) being developed for prevention and treatment of COVID-19.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 80 81 Next page